XTRA:AFXMedical Equipment
Carl Zeiss Meditec (XTRA:AFX) Margin Compression To 4.4% Tests Bullish Earnings Recovery Narrative
Carl Zeiss Meditec (XTRA:AFX) has just posted its Q2 2026 numbers, with revenue at €524.0 million and basic EPS of €0.22, setting the tone for how investors might read the latest quarter. Over recent periods, revenue has moved between €560.0 million in Q2 2025 and €524.0 million in Q2 2026, while EPS has ranged from €0.52 in Q2 2025 to €0.22 in the latest quarter. This gives a clearer view of how the top line and per share earnings have tracked into this result. With trailing net profit...